from the world's big
Re: Is the United States addicted to oil?
Sallai Meridor is the Ambassador of Israel to the U.S.. He served as the Chairman of the Jewish Agency for Israel and the World Zionist Organization from 1999-2005. Prior to this, Mr. Meridor served as the Treasurer of the Jewish Agency and WZO and as the Head of the Settlement Division of the WZO. During the years of his chairmanship, the Jewish Agency underwent a major transformation. The strategy and activities of the Agency were focused on dealing with the Jewish future - the young generation of Jews. Major initiatives included the Masa national effort to bring 20,000 young adults per annum from the Diaspora for a year-long formative experience in Israel, focusing the activities of the Agency in Israel on young Israelis and young Olim, special Aliyah efforts from FSU, Ethiopia, Argentina, and France, and strategic preparations for dealing with the future challenge of Aliyah choice. In response to the war of terror against Israel, a global Jewish mobilization effort and a major emergency campaign was launched. Internally, the budget of the Jewish agency was balanced, agreements to eliminate $700M in debt (which put the agency at risk) were reached, and the Agency took a historic step by restructuring its governing bodies to include significant nonpolitical representation from Israeli society. Finally, with a view towards the Jewish future, the first ever Jewish People Policy Planning Institute was established.
Prior to his work with the Jewish agency, Mr. Meridor served as an advisor to the Minister of Defense and the Minister of Foreign Affairs of the State of Israel. In his governmental service, he was involved in the designing of Israel's foreign and defense policies, played a role in the peace process leading to the Madrid Peace Conference, participated in the negotiations that followed as the representative of the Ministry of Defense, and led Israel's Inter-Agency Steering Committee on Arms Control. Born and educated in Jerusalem, Mr. Meridor earned his B.A. degree at the Hebrew University of Jerusalem. He served as an Intelligence Officer in the IDF. He lives in Kfar Adumim with his wife No'a. They are the proud parents of three daughters.
Sallai Meridor: I think this is a major issue – a major issue for us all. And I think that we have to move fast forward in developing new technologies which will decrease the dependence of western societies and the world as a whole on oil, and especially oil that is coming from regions that are so volatile, vulnerable, and subject to influence of extremist trends. So the more we invest in finding alternative sources of energy, the more we encourage our scientists to focus on this matter, and the more responsible we will be for our children. And I am now wearing my hat as the Ambassador of Israel. This is one of the areas where I hope Israel and the United States could cooperate. We’ve done tremendously in so many areas that are of critical importance both to the United States and Israel. We have – the United States obviously, but Israel too – the best scientists worldwide. And I think that we are to encourage them to sit together and bring promise to the world that our grandchildren will be less dependent on oil than we are.
Recorded on: 7/3/2007 at The Aspen Ideas Festival
Merridor believes that the U.S. must reduce its oil dependency to stabilize the Middle East.
Duke University researchers might have solved a half-century old problem.
- Duke University researchers created a hydrogel that appears to be as strong and flexible as human cartilage.
- The blend of three polymers provides enough flexibility and durability to mimic the knee.
- The next step is to test this hydrogel in sheep; human use can take at least three years.
Duke researchers have developed the first gel-based synthetic cartilage with the strength of the real thing. A quarter-sized disc of the material can withstand the weight of a 100-pound kettlebell without tearing or losing its shape.
Photo: Feichen Yang.<p>That's the word from a team in the Department of Chemistry and Department of Mechanical Engineering and Materials Science at Duke University. Their <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/adfm.202003451" target="_blank">new paper</a>, published in the journal,<em> Advanced Functional Materials</em>, details this exciting evolution of this frustrating joint.<br></p><p>Researchers have sought materials strong and versatile enough to repair a knee since at least the seventies. This new hydrogel, comprised of three polymers, might be it. When two of the polymers are stretched, a third keeps the entire structure intact. When pulled 100,000 times, the cartilage held up as well as materials used in bone implants. The team also rubbed the hydrogel against natural cartilage a million times and found it to be as wear-resistant as the real thing. </p><p>The hydrogel has the appearance of Jell-O and is comprised of 60 percent water. Co-author, Feichen Yang, <a href="https://today.duke.edu/2020/06/lab-first-cartilage-mimicking-gel-strong-enough-knees" target="_blank">says</a> this network of polymers is particularly durable: "Only this combination of all three components is both flexible and stiff and therefore strong." </p><p> As with any new material, a lot of testing must be conducted. They don't foresee this hydrogel being implanted into human bodies for at least three years. The next step is to test it out in sheep. </p><p>Still, this is an exciting step forward in the rehabilitation of one of our trickiest joints. Given the potential reward, the wait is worth it. </p><p><span></span>--</p><p><em>Stay in touch with Derek on <a href="http://www.twitter.com/derekberes" target="_blank">Twitter</a>, <a href="https://www.facebook.com/DerekBeresdotcom" target="_blank">Facebook</a> and <a href="https://derekberes.substack.com/" target="_blank">Substack</a>. His next book is</em> "<em>Hero's Dose: The Case For Psychedelics in Ritual and Therapy."</em></p>
Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.
Vaccines are more likely to get through clinical trials than any other type of drug — but have been given relatively little pharmaceutical industry support during the last two decades, according to a new study by MIT scholars.
What would it be like to experience the 4th dimension?
Physicists have understood at least theoretically, that there may be higher dimensions, besides our normal three. The first clue came in 1905 when Einstein developed his theory of special relativity. Of course, by dimensions we’re talking about length, width, and height. Generally speaking, when we talk about a fourth dimension, it’s considered space-time. But here, physicists mean a spatial dimension beyond the normal three, not a parallel universe, as such dimensions are mistaken for in popular sci-fi shows.
Sallie Krawcheck and Bob Kulhan will be talking money, jobs, and how the pandemic will disproportionally affect women's finances.